Processa Pharmaceuticals (NASDAQ:PCSA – Get Free Report) had its price objective lowered by stock analysts at HC Wainwright from $8.00 to $6.00 in a research note issued to investors on Monday, Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s price target suggests a potential upside of 297.35% from the stock’s previous close.
Processa Pharmaceuticals Price Performance
Shares of PCSA opened at $1.51 on Monday. Processa Pharmaceuticals has a 12 month low of $1.30 and a 12 month high of $18.00. The stock has a fifty day moving average price of $1.76 and a 200 day moving average price of $2.00. The company has a market cap of $4.32 million, a P/E ratio of -0.31 and a beta of 0.60.
Institutional Trading of Processa Pharmaceuticals
An institutional investor recently bought a new position in Processa Pharmaceuticals stock. Spinnaker Trust purchased a new stake in Processa Pharmaceuticals, Inc. (NASDAQ:PCSA – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 76,865 shares of the company’s stock, valued at approximately $26,000. Spinnaker Trust owned 6.25% of Processa Pharmaceuticals at the end of the most recent quarter. Hedge funds and other institutional investors own 91.93% of the company’s stock.
About Processa Pharmaceuticals
Processa Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, develops chemotherapy drugs to improve the safety and efficacy of cancer treatment. Its drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms of killing the cancer cells.
Featured Articles
- Five stocks we like better than Processa Pharmaceuticals
- Earnings Per Share Calculator: How to Calculate EPS
- Columbia Sportswear: A Turnaround Story That’s Gaining Ground
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Lowe’s Stock: Hold Now, Buy it When it Dips
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- ZIM Shipping Stock Soars as the Industry Shows a Bottoming Trend
Receive News & Ratings for Processa Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Processa Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.